JF Timsit
1,388 works · 59,358 citations · h-index 126
Top works
- Clinical and virological data of the first cases of COVID-19 in Europe: a case series
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19
- Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
- Burnout Syndrome in Critical Care Nursing Staff
- Hydrocortisone plus Fludrocortisone for Adults with Septic Shock
- International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
- Attributable Morbidity and Mortality of Catheter-Related Septicemia in Critically Ill Patients: a Matched, Risk-Adjusted, Cohort Study
- Central Vein Catheter-Related Thrombosis in Intensive Care Patients
- Chlorhexidine-Impregnated Sponges and Less Frequent Dressing Changes for Prevention of Catheter-Related Infections in Critically Ill Adults
- Prevalence and Factors of Intensive Care Unit Conflicts: The Conflicus Study
- Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
- Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017
- Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists
- Outcome, functional autonomy, and quality of life of elderly patients with a long-term intensive care unit stay
- Continuous versus Intermittent Infusion of Vancomycin in Severe Staphylococcal Infections: Prospective Multicenter Randomized Study
- Mortality of Nosocomial Pneumonia in Ventilated Patients: Influence of Diagnostic Tools
- Attributable Mortality of Ventilator-Associated Pneumonia: A Reappraisal Using Causal Analysis
- Half the family members of intensive care unit patients do not want to share in the decision-making process: A study in 78 French intensive care units*
- Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study
- Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial